Foxa1 and Foxa2 Interact with the Androgen Receptor to Regulate Prostate and Epididymal Genes Differentially
Overview
Authors
Affiliations
Previous studies from our group have shown that Foxa1 is expressed in the prostate and interacts with the androgen receptor (AR) to regulate prostate-specific genes such as prostate-specific antigen (PSA) and probasin (PB). We report here that Foxa2 but not Foxa1 is expressed in the epididymis. Further, Foxa2 interacts with the AR to regulate the mouse epididymal retinoic acid binding protein (mE-RABP) gene, an epididymis-specific gene. Binding of Foxa2 to the mE-RABP promoter was confirmed by gel-shift and chromatin immunoprecipitation (ChIP) assays. Overexpression of Foxa2 suppresses androgen activation of the mE-RABP promoter while overexpression of Foxa2 with prostate-specific promoters activates gene expression in an androgen-independent manner. GST pull-down assays determined that both Foxa1 and Foxa2 physically interact with the DNA binding domain of the AR. The interaction between Foxa proteins and AR was further confirmed by gel-shift assays where Foxa protein was recruited to AR binding oligomers even when Foxa binding sites were not present, and AR was recruited to Foxa binding oligomers even in the absence of an AR binding site. Given that Foxa1 and Foxa2 proteins are expressed differentially in the prostate and epididymis, these data suggest that the Foxa proteins have distinct effects on AR-regulated genes in different male reproductive accessory organs.
Neuroendocrine transdifferentiation in human cancer: molecular mechanisms and therapeutic targets.
Jiang J, Han D, Wang J, Wen W, Zhang R, Qin W MedComm (2020). 2024; 5(10):e761.
PMID: 39372390 PMC: 11450264. DOI: 10.1002/mco2.761.
Goglia A, Alshalalfa M, Khan A, Isakov D, Hougen H, Swami N J Natl Cancer Inst. 2024; 117(1):188-197.
PMID: 39254651 PMC: 11717412. DOI: 10.1093/jnci/djae224.
Henon C, Vibert J, Eychenne T, Gruel N, Colmet-Daage L, Ngo C Cell Rep Med. 2024; 5(6):101582.
PMID: 38781959 PMC: 11228554. DOI: 10.1016/j.xcrm.2024.101582.
FOXA1 and FOXA2: the regulatory mechanisms and therapeutic implications in cancer.
Liu N, Wang A, Xue M, Zhu X, Liu Y, Chen M Cell Death Discov. 2024; 10(1):172.
PMID: 38605023 PMC: 11009302. DOI: 10.1038/s41420-024-01936-1.
Tam K, Liu L, Hsing M, Dalal K, Thaper D, McConeghy B Sci Rep. 2024; 14(1):7082.
PMID: 38528115 PMC: 10963789. DOI: 10.1038/s41598-024-57854-w.